A. Bergeman

Pharmacological treatment of short-coupled idiopathic ventricular fibrillation: A review

A. Wilde, P. Postema, C. van der Werf, 2023, Indian pacing and electrophysiology journal.

Outcomes in Dutch DPP6 risk haplotype for familial idiopathic ventricular fibrillation: a focused update

P. Postema, A. Wilde, P. Volders, 2023, Netherlands Heart Journal.

Accuracy of mobile 6-lead electrocardiogram device for assessment of QT interval: a prospective validation study

M. Winter, G. Somsen, I. Tulevski, 2022, Netherlands Heart Journal.

Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts

B. D. de Jong, P. Corstjens, A. Geluk, 2023, BMC Infectious Diseases.

Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

M. LaPage, A. Bergeman, MD Michael J. Ackerman, 2023, Circulation.

Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor

T. Robyns, C. van der Werf, A. Wilde, 2023, Netherlands Heart Journal.

Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.

C. van der Werf, A. Bergeman, A. A. Wilde, 2023, Cardiac electrophysiology clinics.

Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline‐enhanced prophylactic leprosy treatment

A. Piubello, N. Ortuño-Gutiérrez, E. Hasker, 2024, Clinical and translational science.